Earnings Call · Q2 FY2021·2021-07-29

Q2 21EPS -100.00%*·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS -66.67%·Rev n/aQ3 20EPS +100.00%*·Rev n/a⚠ consensus missing

NovoCure Ltd NVCR

Ingrid Goldberg — Unknown

Bill Doyle — Executive Chairman

Asaf Danziger — Chief Executive Officer

Ashley Cordova — Chief Financial Officer

−9.9%1d on move date−10.3% vs SPY3d−17.2%5d−15.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NVCR calls or request research access.

More NVCR calls Browse calls Request research access